Stacie Sawchak Aarestad: Lawyer with Edwards Wildman Palmer LLP

Stacie Sawchak Aarestad

Partner
Boston,  MA  U.S.A.
Phone617-239-0314

Peer Rating
N/R
 N/R

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials
 

Practice Areas

  • Business Law
  • Mergers & Acquisitions
  • Securities Offerings and Public Company Counseling
  • Compliance for Risk Management
  • Life Sciences
  • Healthcare
 
University Colgate University, A.B., magna cum laude, 1991
 
Law SchoolBoston University School of Law, J.D., magna cum laude, 1997
 
Admitted1997, Massachusetts
 
Memberships 

Membership

American Bar Association
Massachusetts Bar Association
Boston Bar Association

 
LanguagesRussian
 
BornBethesda, Maryland, 1969
 
Biography

Stacie Aarestad is the chair of the Firm's Securities Offering and Public Company Counseling Practice Group. She focuses her practice on corporate and securities law matters, public company representation and merger and acquisition transactions. She represents issuers in a broad range of capital market transactions, including public and private offerings of debt and equity securities. She also advises companies with respect to tender offers, exchange offers, debt repurchases and stock buybacks. A significant portion of Stacie's practice includes counseling public company clients on their ongoing reporting obligations, corporate governance and related regulatory matters, including the Sarbanes-Oxley Act of 2002. She also regularly counsels clients with respect to Section 16 matters, insider trading regulations, executive compensation matters and various other matters affecting public companies and their officers and directors.

Representation of:

•Bolt Technology Corporation (NASDAQ: BOLT) in its proposed sale to Teledyne Technologies Incorporated (NYSE: TDY).
•Enanta Pharmaceuticals, Inc. in its initial public offering of common stock.
•Dyax Corp. in public securities offerings including:

•$80, 000, 000 underwritten public offering of common stock;
•$65, 000, 000 underwritten public offering of common stock;
•$30, 000, 000 registered direct offering of common stock;
•$63, 537, 500 underwritten public offering of common stock;
•$21, 000, 000 underwritten public offering of common stock;
•$17, 250, 000 underwritten public offering of common stock;
•$50, 000, 000 Committed Equity Financing Facility with Azimuth Opportunity Ltd.; and
•$44, 300, 000 underwritten public offering of common stock.
•Dyax Corp. in connection with secured loans including:

•$65, 000, 000 loan agreement with Cowen Healthcare Royalty Partners, L.P., consisting of a $50, 000, 000 Tranche A loan and a $15, 000, 000 Tranche B loan, secured by Dyax's phage display Licensing and Funded Research Program; and
•$30, 000, 000 royalty interest assignment agreement with Paul Capital Partners.
•Lamar Advertising Company in high yield and convertible debt offerings and tender offers including:

•$510, 000, 000 144A offering of 5 % Senior Notes due 2024;
•$535, 000, 000 144A offering of 5% Senior Subordinated Notes due 2023 with follow-on exchange offer;
•$500, 000, 000 144A offering of 5 % Senior Subordinated Notes due 2022 with follow-on exchange offer;
•$400, 000, 000 144A offering of 7 % Senior Subordinated Notes due 2018 with follow-on exchange offer;
•Cash Tender Offer and Consent Solicitation for all of Lamar's then outstanding 7 % Senior Subordinated Notes due 2013;
•Tender Offer to eligible employees and directors to exchange certain outstanding options to purchase the Company's Class A common stock for a lesser number of new options;
•Cash Tender Offers for all of Lamar's then outstanding 2 % Convertible Notes due 2010-Series B;
•$350, 000, 000 144A offering of 9% Senior Notes due 2014 with follow-on exchange offer;
•$275, 000, 000 144A offering of 6 % Senior Subordinated Notes due 2015-Series C with follow-on exchange offer;
•Exchange Offer of a new series of 2 % Convertible Notes due 2010-Series B for all outstanding 2 % Convertible Notes due 2010;
•$216, 000, 000 144A offering of 6 % Senior Subordinated Notes due 2015-Series B with follow-on exchange offer; and
•$400, 000, 000 144A offering of 6 % Senior Subordinated Notes due 2015 with follow-on exchange offer.
•NewStar Financial, Inc. in its $125, 000, 000 PIPE with institutional investors including, Corsair Capital, Union Square Partners and Och-Ziff Capital Management, Swiss Re and SAB Capital.

 
ISLN912618980
 

Documents by this lawyer on Martindale.com

Subscribe to this feed

SEC Provides Helpful Guidance on Accredited Investor Verification
Stacie Sawchak Aarestad,Matthew C. Dallett,Stanley Keller,Eugene W. McDermott, July 14, 2014
On July 3, 2014, the staff of the SEC’s Division of Corporation Finance issued guidance on reasonable steps to verify the accredited investor status of purchasers for purposes of the Rule 506(c) exemption that permits general solicitation. The guidance, which is in the form of several...
Profile Visibility
#585 in weekly profile views out of 19,507 lawyers in Boston, Massachusetts
#46,159 in weekly profile views out of 1,571,845 total lawyers Overall

Office Information

Stacie Sawchak Aarestad

111 Huntington Avenue
BostonMA 02199-7613




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now